Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 9;3(11):15182-15192.
doi: 10.1021/acsomega.8b01752. eCollection 2018 Nov 30.

Versatile Synthetic Approach for Selective Diversification of Bicyclic Aza-Diketopiperazines

Affiliations

Versatile Synthetic Approach for Selective Diversification of Bicyclic Aza-Diketopiperazines

Florent Péron et al. ACS Omega. .

Abstract

Herein, we report a convenient synthesis of unprecedented aza-diketopiperazines (aza-DKPs). The strategy is based on selective diversification of bicyclic aza-DKP scaffolds by click reaction, N-acylation, and/or N-alkylation. These scaffolds containing either azido or amino groups were obtained by a key Rh(I)-catalyzed hydroformylative cyclohydrocarbonylation reaction of allyl-substituted aza-DKP. The methodology is readily amenable to the parallel synthesis of original aza-DKPs to enlarge the chemical diversity of aza-heterocycles.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
General structure of novel bicyclic aza-DKPs and selected examples of known biologically active 2,5-DKPs.
Figure 2
Figure 2
Design of aza-DKP scaffolds 5 and 8 ready to functionalize.
Scheme 1
Scheme 1. Preparation of Aza-DKP Scaffolds 5 and 8
Scheme 2
Scheme 2. Synthesis of Dehydroalanine-Containing Aza-DKP 9 from Aza-DKP 5 and 6
Scheme 3
Scheme 3. Functionalization of Aza-DKP Scaffold 8
Scheme 4
Scheme 4. Access to Disubstituted Aza-DKPs by N-Alkylation of Scaffold 11a

References

    1. Stockwell B. R. Exploring biology with small organic molecules. Nature 2004, 432, 846–854. 10.1038/nature03196. - DOI - PMC - PubMed
    1. Lovering F.; Bikker J.; Humblet C. Escape from flatland: increasing saturation as an approach to improving clinical success. J. Med. Chem. 2009, 52, 6752–6756. 10.1021/jm901241e. - DOI - PubMed
    1. Borthwick A. D. 2,5-Diketopiperazines: synthesis, reactions, medicinal chemistry, and bioactive natural products. Chem. Rev. 2012, 112, 3641–3716. 10.1021/cr200398y. - DOI - PubMed
    1. Hoffman R. V.; Nayyar N. Reaction of hydrazines with.alpha.-lactams for the preparation of 1,2,4-triazine-3,6-diones and aza-urea peptide mimetics. J. Org. Chem. 1995, 60, 5992–5994. 10.1021/jo00123a048. - DOI
    2. Hoffman R. V.; Reddy M. M.; Klumas C. M.; Cervantes-Lee F. The reactions of hydrazines with α-lactams. Regiochemistry of hydrazine addition and subsequent ring closure to N-aminohydantoins or 1,2,4-triazine-3,6-diones. J. Org. Chem. 1998, 63, 9128–9130. 10.1021/jo981650c. - DOI
    1. Obreza A.; Urleb U. A two-step synthesis of hexahydropyrrolo-[1,2-d][1,2,4]triazine-1,4-dione and related compounds. Synth. Commun. 2003, 33, 1011–1018. 10.1081/SCC-120016366. - DOI